Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 363 followers

Latest posts

Last updated about 5 hours ago

‘SNL’ star Kenan Thompson serves up a new campaign for Phathom’s Voquezna

about 5 hours ago

Funnyman Kenan Thompson is opening up about the not-so-funny experience of living...

Eli Lilly CEO on Trump's tariffs: 'It'll be hard to come back from here'

about 5 hours ago

President Donald Trump’s announcement on Wednesday that pharmaceuticals imported to the U.S...

Amgen wins key rare disease nod for Uplizna, checking off one goal in expansion push

about 5 hours ago

Uplizna is now the first FDA-approved treatment for immunoglobulin G4-related disease, a...

FDA staff cuts could disrupt drug reviews, putting agency's critical funding programs at risk: reports

about 5 hours ago

Massive cuts at the FDA have hit staff tied to drug reviews...

GSK, Pfizer resolve RSV patent feud amid vaccine market uncertainty

about 6 hours ago

As the RSV vaccine field grapples with a significantly reduced market size...

Meet the Tech That’s Modernizing How HCPs Get Meds to Patients

about 7 hours ago

Healthcare providers face increasing complexity in prescribing due to rising costs and...

Fierce Pharma Asia—Pharma CEOs meet Xi Jinping; Trump's tariffs; BioNTech's bispecific data

about 8 hours ago

Several pharma CEOs met with Chinese President Xi Jinping in Beijing. Donald...

Amid FDA tumult, agency misses decision deadline on Novavax's COVID shot

1 day ago

Amid a period of great upheaval at the agency, the FDA has...

After patient death, Sarepta and Roche pause 3 trials of gene therapy Elevidys in Europe

1 day ago

In response to a request from the European Medicines Agency following the...

Novo's commercial strategy head hits the exit, prompting a slew of executive team shakeups

1 day ago

Camilla Sylvest is stepping down from her role as executive vice president...

Vanrafia, 2nd drug in Novartis' IgAN troika, crosses FDA finish line in payday for Chinook investors

1 day ago

The FDA's approval for Novartis' atrasentan in the kidney disease IgAN means...

Nxera Pharma appoints AstraZeneca alum as inaugural commercial chief

1 day ago

As Nxera Pharma proceeds into the “next era” implied by its name—following...